Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer

Despite advances in cancer therapy, the clinical outcome of patients with gastric cancer remains poor, largely due to tumor heterogeneity. Thus, finding a hidden vulnerability of clinically refractory subtypes of gastric cancer is crucial. Here, we report that chemoresistant gastric cancer cells rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Nahee, Yoon, Bo Kyung, Chun, Kyu-Hye, Kim, Hyeonhui, Lee, Yoseob, Kim, Jae-Won, Jeon, Hyeonuk, Kim, Tae-Hyun, Kim, Mi-Young, Fang, Sungsoon, Cheong, Jae-Ho, Kim, Jae-woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689497/
https://www.ncbi.nlm.nih.gov/pubmed/37919422
http://dx.doi.org/10.1038/s12276-023-01109-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689497/
https://www.ncbi.nlm.nih.gov/pubmed/37919422
http://dx.doi.org/10.1038/s12276-023-01109-7

Ejemplares similares